JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB18529

Anti-LAMP2B 抗体 - Lysosome Marker

Anti-LAMP2B antibody - Lysosome Marker

4

(4 Reviews)

|

(34 Publications)

Rabbit Polyclonal LAMP2 antibody. Lysosome marker. Suitable for WB and reacts with Human samples. Cited in 34 publications.

別名を表示する

CD107b, Lysosome-associated membrane glycoprotein 2, LAMP-2, Lysosome-associated membrane protein 2, CD107 antigen-like family member B, LGP-96, LAMP2

1 Images
Western blot - Anti-LAMP2B antibody - Lysosome Marker (AB18529)
  • WB

Unknown

Western blot - Anti-LAMP2B antibody - Lysosome Marker (AB18529)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The blot was incubated with ab18529 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.

LAMP2B undergoes extensive glycosylation so ab18529 detects a band of 110 kDa by Western blot.

All lanes:

Western blot - Anti-LAMP2B antibody - Lysosome Marker (ab18529) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg

Lane 2:

HEK293 (Human) Whole Cell Lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG H&L (HRP) preadsorbed at 1/50000 dilution

Predicted band size: 45 kDa

Observed band size: 110 kDa,22 kDa,33 kDa,34 kDa,65 kDa

true

Exposure time: 4min

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

This product has low sequence homology with Mouse LAMP2B (67%), and high sequence homology with Mouse LAMP2C (91.7%).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Cow": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

LAMP2B also known as lysosome-associated membrane glycoprotein 2b acts mechanically as a lysosomal protein essential for normal cellular function. It has a mass of approximately 45 kDa and is highly expressed in tissues such as the heart skeletal muscle and liver. The protein integrates into the lysosomal membrane contributing to cellular degradation processes and maintaining lysosomal integrity.
Biological function summary

LAMP2B facilitates lysosomal fusion with autophagosomes aiding the process of autophagy important for cellular maintenance and survival. It forms part of a complex involved in chaperone-mediated autophagy a specific system of protein degradation. This adaptation prevents intracellular damage with LAMP2B playing a critical role in maintaining cellular homeostasis.

Pathways

Studies indicate that LAMP2B is significantly involved in the autophagy-lysosome pathway. It works alongside key proteins like LC3 and Beclin-1 which drive the formation and function of autophagosomes. Through this LAMP2B influences cellular recycling and energy balance linking it closely to cellular stress response and homeostatic regulations.

LAMP2B deficiency can lead to Danon disease a severe condition characterized by cardiomyopathy and muscle weakness. Research also links LAMP2B dysfunction to Parkinson's disease where it interacts with proteins such as alpha-synuclein suggesting a role in neurodegenerative processes. Ensuring proper LAMP2B function is essential to prevent these disorders.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Lysosomal membrane glycoprotein which plays an important role in lysosome biogenesis, lysosomal pH regulation and autophagy (PubMed : 11082038, PubMed : 18644871, PubMed : 24880125, PubMed : 27628032, PubMed : 36586411, PubMed : 37390818, PubMed : 8662539). Acts as an important regulator of lysosomal lumen pH regulation by acting as a direct inhibitor of the proton channel TMEM175, facilitating lysosomal acidification for optimal hydrolase activity (PubMed : 37390818). Plays an important role in chaperone-mediated autophagy, a process that mediates lysosomal degradation of proteins in response to various stresses and as part of the normal turnover of proteins with a long biological half-live (PubMed : 11082038, PubMed : 18644871, PubMed : 24880125, PubMed : 27628032, PubMed : 36586411, PubMed : 8662539). Functions by binding target proteins, such as GAPDH, GPX4, NLRP3 and MLLT11, and targeting them for lysosomal degradation (PubMed : 11082038, PubMed : 18644871, PubMed : 24880125, PubMed : 36586411, PubMed : 8662539). In the chaperone-mediated autophagy, acts downstream of chaperones, such as HSPA8/HSC70, which recognize and bind substrate proteins and mediate their recruitment to lysosomes, where target proteins bind LAMP2 (PubMed : 36586411). Plays a role in lysosomal protein degradation in response to starvation (By similarity). Required for the fusion of autophagosomes with lysosomes during autophagy (PubMed : 27628032). Cells that lack LAMP2 express normal levels of VAMP8, but fail to accumulate STX17 on autophagosomes, which is the most likely explanation for the lack of fusion between autophagosomes and lysosomes (PubMed : 27628032). Required for normal degradation of the contents of autophagosomes (PubMed : 27628032). Required for efficient MHC class II-mediated presentation of exogenous antigens via its function in lysosomal protein degradation; antigenic peptides generated by proteases in the endosomal/lysosomal compartment are captured by nascent MHC II subunits (PubMed : 15894275, PubMed : 20518820). Is not required for efficient MHC class II-mediated presentation of endogenous antigens (PubMed : 20518820).. Isoform LAMP-2C. Modulates chaperone-mediated autophagy. Decreases presentation of endogenous antigens by MHCII. Does not play a role in the presentation of exogenous and membrane-derived antigens by MHCII.. (Microbial infection) Supports the FURIN-mediated cleavage of mumps virus fusion protein F by interacting with both FURIN and the unprocessed form but not the processed form of the viral protein F.
See full target information LAMP2

文献 (34)

Recent publications for all applications. Explore the full list and refine your search

Molecular cancer 23:227 PubMed39390584

2024

Chaperone-mediated autophagy modulates Snail protein stability: implications for breast cancer metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Ki-Jun Ryu,Ki Won Lee,Seung-Ho Park,Taeyoung Kim,Keun-Seok Hong,Hyemin Kim,Minju Kim,Dong Woo Ok,Gu Neut Bom Kwon,Young-Jun Park,Hyuk-Kwon Kwon,Cheol Hwangbo,Kwang Dong Kim,J Eugene Lee,Jiyun Yoo

Autophagy 21:352-373 PubMed39212196

2024

Impaired degradation of PLCG1 by chaperone-mediated autophagy promotes cellular senescence and intervertebral disc degeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Zhangrong Cheng,Weikang Gan,Qian Xiang,Kangcheng Zhao,Haiyang Gao,Yuhang Chen,Pengzhi Shi,Anran Zhang,Gaocai Li,Yu Song,Xiaobo Feng,Cao Yang,Yukun Zhang

Journal of nanobiotechnology 22:281 PubMed38790015

2024

Chondrocyte-targeted exosome-mediated delivery of Nrf2 alleviates cartilaginous endplate degeneration by modulating mitochondrial fission.

Applications

Unspecified application

Species

Unspecified reactive species

Zhidi Lin,Guangyu Xu,Xiao Lu,Siyang Liu,Fei Zou,Xiaosheng Ma,Jianyuan Jiang,Hongli Wang,Jian Song

Journal of nanobiotechnology 21:341 PubMed37736726

2023

Engineering exosomes derived from subcutaneous fat MSCs specially promote cartilage repair as miR-199a-3p delivery vehicles in Osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Shu Zhao,Guanghui Xiu,Jian Wang,Yi Wen,Jinyuan Lu,Baitong Wu,Guangming Wang,Danjing Yang,Bin Ling,Dajiang Du,Jun Xu

Molecular medicine reports 28: PubMed37232338

2023

Placental homing peptide guides HIF1α‑silenced exosomes conjugates for targeted enhancement of invasion of trophoblast cells.

Applications

Unspecified application

Species

Unspecified reactive species

Fangrong Chen,Hui Cen,Dongrui Mao,Rong Feng

PLoS pathogens 18:e1010824 PubMed36067270

2022

Components of the LINC and NPC complexes coordinately target and translocate a virus into the nucleus to promote infection.

Applications

Unspecified application

Species

Unspecified reactive species

Chelsey C Spriggs,Grace Cha,Jiaqian Li,Billy Tsai

Frontiers in oncology 12:822805 PubMed35982974

2022

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qinhua Liu,Guanrong Dai,Yi Wu,Mingxia Zhang,Mingya Yang,Xiaonan Wang,Mingyue Song,Xiaodan Li,Ruixiang Xia,Zhengsheng Wu

Science advances 8:eabm1140 PubMed35333565

2022

LAMP2A regulates the loading of proteins into exosomes.

Applications

Unspecified application

Species

Unspecified reactive species

João Vasco Ferreira,Ana da Rosa Soares,José Ramalho,Catarina Máximo Carvalho,Maria Helena Cardoso,Petra Pintado,Ana Sofia Carvalho,Hans Christian Beck,Rune Matthiesen,Mónica Zuzarte,Henrique Girão,Guillaume van Niel,Paulo Pereira

Molecular therapy oncolytics 24:897-908 PubMed35571376

2022

Potential for reversing -mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Phuong Xuan Tran,Jun Inoue,Hiroyuki Harada,Johji Inazawa

Biochemistry and biophysics reports 26:101009 PubMed34027135

2021

Augmentation of lenvatinib efficacy by topical treatment of ointment in anaplastic thyroid cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Masahiro Kishikawa,Jun Inoue,Hidetoshi Hamamoto,Katsunori Kobayashi,Takahiro Asakage,Johji Inazawa
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com